Hello, I am Seung-Hoon Han, CEO of AIMS BioScience. Thank you for your interest in AIMS and for visiting our website.

AIMS brings multidisciplinary expertise to help clients navigate drug development and make confident, evidence-based decisions—especially in early development.

Our key services include:

• Target Product Profile (TPP) definition
• Nonclinical & clinical development strategy
• Study design (nonclinical/clinical)
• Advanced CMC support (e.g., advanced biologics)
• Clinical pharmacology (dose, DDI, etc.)
• Quantitative pharmacology (integrated rationale)
• Regulatory strategy & execution (KR/Global)
• Scientific support for licensing-out
• Support for investigator-initiated studies

We are trusted by 170+ clients across 320+ projects. If you have any questions in drug R&D, please feel free to contact us—AIMS is here to support you.